Institutional Ownership Sensei Biotherapeutics, Inc. (SNSE)
This table provides information about the institutional ownership of Sensei Biotherapeutics, Inc. (SNSE). We have compiled data on the 27 institutions that hold shares in the stock, with a total of 2.32 Million shares, which have been reported (via 13F filing form) to have a value of $1.7 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Newtyn Management, LLC
New York, NY |
May 15, 2024 Q1 2024 |
930,230
shares
|
$679,067
0.21% of portfolio
|
Q1 2024
Reduced 40.83%
|
|
Vanguard Group Inc
Valley Forge, PA |
May 10, 2024 Q1 2024 |
573,844
shares
|
$418,906
0.0% of portfolio
|
Q1 2024
Added 0.03%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
May 13, 2024 Q1 2024 |
211,000
shares
|
$154,030
0.0% of portfolio
|
Q1 2024
Added 47.03%
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2024 Q1 2024 |
136,318
shares
|
$99,512
0.0% of portfolio
|
Q3 2023
Added 39.09%
|
|
Bridgeway Capital Management, LLC
Houston, TX |
May 15, 2024 Q1 2024 |
112,900
shares
|
$82,417
0.0% of portfolio
|
Q4 2022
Reduced 30.69%
|
|
Bank Of America Corp
Charlotte, NC |
May 15, 2024 Q1 2024 |
90,763
shares
|
$66,256
0.0% of portfolio
|
Q1 2024
Reduced 0.03%
|
|
Black Rock Inc.
New York, NY |
May 10, 2024 Q1 2024 |
33,582
shares
|
$24,514
0.0% of portfolio
|
Q1 2024
Reduced 3.54%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
May 15, 2024 Q1 2024 |
32,587
shares
|
$23,788
0.0% of portfolio
|
Q1 2024
Reduced 14.91%
|
|
Northern Trust Corp
Chicago, IL |
May 14, 2024 Q1 2024 |
26,049
shares
|
$19,015
0.0% of portfolio
|
Q3 2022
Added 67.6%
|
|
State Street Corp
Boston, MA |
May 15, 2024 Q1 2024 |
25,774
shares
|
$18,815
0.0% of portfolio
|
Q2 2022
Reduced 88.57%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2024 Q1 2024 |
23,864
shares
|
$17,420
0.0% of portfolio
|
Q1 2024
Reduced 7.51%
|
|
Cresset Asset Management, LLC
Chicago, IL |
May 15, 2024 Q1 2024 |
19,671
shares
|
$14,359
0.0% of portfolio
|
Q1 2024
New holding
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
May 15, 2024 Q1 2024 |
19,000
shares
|
$13,870
0.0% of portfolio
|
Q4 2023
Reduced 2.06%
|
|
Leo Wealth, LLC
Hurst, TX |
May 09, 2024 Q1 2024 |
14,845
shares
|
$10,836
0.0% of portfolio
|
Q4 2023
New holding
|
|
Leo Brokerage, LLC
|
Jul 25, 2023 Q2 2023 |
14,845
shares
|
$10,836
0.0% of portfolio
|
Q3 2021
New holding
|
|
Raymond James & Associates
St Petersburg, FL |
Apr 22, 2024 Q1 2024 |
14,000
shares
|
$10,220
0.0% of portfolio
|
Q1 2023
Reduced 26.32%
|
|
Morgan Stanley
New York, NY |
May 15, 2024 Q1 2024 |
12,219
shares
|
$8,919
0.0% of portfolio
|
Q1 2024
Added 5479.45%
|
|
Deuterium Capital Management, LLC
|
May 06, 2024 Q1 2024 |
11,000
shares
|
$8,030
0.02% of portfolio
|
Q1 2023
Reduced 7.56%
|
|
Two Sigma Investments, LP
New York, NY |
May 15, 2024 Q1 2024 |
10,176
shares
|
$7,428
0.0% of portfolio
|
Q4 2023
Reduced 6.44%
|
|
Tower Research Capital LLC (Trc)
New York, NY |
May 15, 2024 Q1 2024 |
6,713
shares
|
$4,900
0.0% of portfolio
|
Q1 2024
Reduced 20.51%
|
|
Banque Cantonale Vaudoise
|
Apr 10, 2024 Q1 2024 |
3,900
shares
|
$2,847
0.0% of portfolio
|
Q1 2022
Added 333.33%
|
|
Jpmorgan Chase & CO
New York, NY |
May 10, 2024 Q1 2024 |
668
shares
|
$487
0.0% of portfolio
|
Q4 2022
Reduced 61.0%
|
|
Ubs Group Ag
|
May 13, 2024 Q1 2024 |
139
shares
|
$101
0.0% of portfolio
|
Q1 2024
New holding
|
|
Wells Fargo & Company
San Francisco, CA |
May 10, 2024 Q1 2024 |
133
shares
|
$97
0.0% of portfolio
|
Q1 2024
Added 1.53%
|
|
Royal Bank Of Canada
Toronto, A6 |
May 15, 2024 Q1 2024 |
53
shares
|
$38
0.0% of portfolio
|
Q1 2024
Reduced 90.15%
|